Groups tell Congress to back off fight over ESA dosing decisions

October 19, 2007

Groups say cancer drug dosing best measured by CMS, Medicaid.

A handful of consumer and health groups have fired the latest salvo in the ongoing battle over Medicare reimbursements for anemia drugs. In a letter sent Wednesday to Congress, the groups-including Consumers Union, U.S. PIRG, the National Research Center for Women & Families, the National Women's Health Network, and the Center for Medical Consumers-urged lawmakers to back off the fight over a CMS